作者: Iqbal A. Bukhari
DOI:
关键词:
摘要: We are reporting a case of 23-year-old Saudi female with persistent chronic plaque psoriasis who was given subcutaneous Efaluzimab 0.8 mg/kg/week for 14 weeks. During that period the patient developed multiple adverse reactions followed by severe rebound. The is presented to highlight importance managing patients on Efalizumab carefully and closely.